Central pontine myelinolysis interventions: Difference between revisions

	Central pontine myelinolysis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Central pontine myelinolysis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Central pontine myelinolysis interventions On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Central pontine myelinolysis interventions All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Central pontine myelinolysis interventions
CDC on Central pontine myelinolysis interventions
Central pontine myelinolysis interventions in the news
Blogs on Central pontine myelinolysis interventions
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Central pontine myelinolysis interventions

Latest revision as of 22:21, 16 January 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

There are no recommended therapeutic interventions for the management of central pontine myelinolysis.

There are no recommended therapeutic interventions for the management of central pontine myelinolysis.

@@ Line 4: / Line 4: @@
 ==Overview==
-There are no recommended therapeutic interventions for the management of [disease name].
+There are no recommended therapeutic interventions for the management of central pontine myelinolysis.
-OR
-[Name of intervention] is not the first-line treatment option for patients with [disease name]. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
-OR
-The mainstay of treatment for [disease name] is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
-OR
-The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis.
-OR
-[Name of intervention] is the mainstay of treatment for [disease or malignancy].
 ==Indications==
-The mainstay of treatment for TT is medical therapy.
+There are no recommended therapeutic interventions for the management of central pontine myelinolysis.
 ==References==